This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of skin, other sites/unspecified
CD2_INSITU_SKIN_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin, other sites/unspecified
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin, other sites/unspecified
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 393 | 179 | 214 |
| Unadjusted period prevalence (%) | 0.08 | 0.06 | 0.09 |
| Median age at first event (years) | 76.42 | 74.70 | 77.86 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 324
- Matched controls
- 3238
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
4869.8
231.3
195
*
L57.0
ICD-10 Finland
Actinic keratosis
48.1
179.5
240
181
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
+∞
165.1
144
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
51.3
127.5
154
56
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
442.7
122.2
115
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
26.5
121.1
183
151
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
66.1
101.9
116
27
ZXC50
NOMESCO Finland
Cryotherapy
48.8
93.4
113
35
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
54.3
90.6
107
29
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
539.1
86.4
82
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
85.2
78
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
109.0
83.0
88
11
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
346.3
81.5
79
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
28.6
79.1
110
57
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
836.9
70.9
67
*
TQW99
NOMESCO Finland
Other minor procedure on skin
25.6
67.8
97
53
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
32.8
62.0
82
33
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
190.6
61.3
62
*
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
179.4
58.0
59
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
20.9
55.8
85
54
R23.8
ICD-10 Finland
Other and unspecified skin changes
9.1
54.1
131
225
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
49.2
46
*
S18
ICPC
Laceration/cut
5.6
46.1
221
891
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
177.8
45.1
46
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
41.5
39
*
D06BB10
ATC
imiquimod; topical
15.1
39.7
68
56
ZZR00
NOMESCO Finland
Flap of skin
70.4
38.2
43
7
SPAT1153
SPAT
Removal of sutures
4.8
38.0
181
670
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
27.9
36.6
50
21
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
27.9
36.6
50
21
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
39.9
33.7
42
12
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
32.9
31
*
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
+∞
31.8
30
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
33.3
31.6
41
14
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
27.3
31.4
43
18
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
331.4
30.3
30
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
29.6
28
*
127
Kela drug reimbursment
Transplant complication
113.8
29.2
31
*
ZZA00
NOMESCO Finland
Split skin graft
16.0
28.6
47
34
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
28.5
27
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
26.4
25
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
11.1
24.8
48
50
L82
ICD-10 Finland
Seborrhoeic keratosis
4.6
24.6
99
284
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
24.3
23
*
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
+∞
24.3
23
*
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
+∞
24.3
23
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
24.3
23
*
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
73.2
24.2
27
*
Z94.0
ICD-10 Finland
Kidney transplant status
134.9
23.9
25
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
23.2
22
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
23.2
22
*
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
56.2
22.4
26
5
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
22.1
21
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
22.1
21
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
22.1
21
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
+∞
22.1
21
*
S77
ICPC
Malignant neoplasm of skin
+∞
21.1
20
*
130
Kela drug reimbursment
Malignant tumour
+∞
21.1
20
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
20.0
19
*
ZXC20
NOMESCO Finland
Use of chemical agents
17.0
19.7
31
20
116
Kela drug reimbursment
Prostate cancer
+∞
18.9
18
*
L04AD01
ATC
ciclosporin; systemic
30.8
17.7
23
8
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
53.0
17.2
20
*
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
+∞
16.8
16
*
DAB00
NOMESCO Finland
Excision of lesion of auricle
29.3
16.7
22
8
L04AA06
ATC
mycophenolic acid; systemic
29.3
16.7
22
8
L04AA01
ATC
[U] ciclosporin; systemic
21.5
16.7
24
12
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
178.7
16.6
17
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
178.7
16.6
17
*
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
12.1
16.1
29
26
TQW80
NOMESCO Finland
Local dermatologic skincare
10.0
16.1
32
35
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
15.7
15
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
15.7
15
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
15.6
182
1058
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.2
15.3
42
76
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
9.4
15.1
31
36
ZQZ00
NOMESCO Finland
Treatment of several skin areas
59.5
14.9
17
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
15.1
14.8
24
17
C44.82
ICD-10 Finland
Overall spinocellular carcinoma of the skin
+∞
14.7
14
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
14.7
14
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
14.7
14
*
DAB10
NOMESCO Finland
Partial excision of auricle
+∞
14.7
14
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
156.6
14.6
15
*
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
31.6
14.0
18
6
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.2
13.8
84
323
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
145.7
13.5
14
*
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
145.7
13.5
14
*
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
145.7
13.5
14
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
12.2
13.5
24
21
A98
ICPC
Health maint/preventive medicine
4.4
13.5
304
2511
XQ845
NOMESCO Finland
Dermatoscopy
27.1
13.5
18
7
J01DB01
ATC
cefalexin; oral
2.8
13.4
267
2015
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
8.3
13.2
29
38
JN4BD
NOMESCO Finland
Extensive body CT
5.1
12.7
41
90
QDA50
NOMESCO Finland
Cryotherapy of skin of lower limb
134.9
12.5
13
*
D07AC01
ATC
betamethasone; topical
2.4
12.2
139
767
B07.9
ICD-10 Finland
Verruca simplex
8.9
12.0
25
30
E0000UV
ATC
NA
2.4
12.0
147
840
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
48.5
12.0
14
*
A12AA04
ATC
calcium carbonate; oral
11.1
11.9
22
21
N02BE01
ATC
paracetamol; systemic, rectal
3.2
11.8
289
2341
ZZA50
NOMESCO Finland
Full thickness skin graft
67.4
11.7
13
*
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
23.9
11.7
16
7
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
11.6
56
180
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
11.5
137
768
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
11.5
11
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
+∞
11.5
11
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
S29
ICPC
Skin symptom/complaint other
2.9
11.4
80
332
XQ848
NOMESCO Finland
Dermatological photography
8.1
11.4
25
33
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
7.9
11.2
25
34
WX110
NOMESCO Finland
Local anesthesy
2.2
11.0
202
1376
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.9
10.9
72
288
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
22.4
10.8
15
7
XX3DW
NOMESCO Finland
Time consuming IT work
5.1
10.6
33
70
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
10.5
10
*
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
+∞
10.5
10
*
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
+∞
10.5
10
*
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
10.5
10
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
+∞
10.5
10
*
8070/3-C44.7
ICD-O-3
Squamous cell carcinoma, NOS, of skin of lower limb and hip
+∞
10.5
10
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
10.1
10.4
20
21
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
10.3
137
798
Z3231
NOMESCO Finland
Registered nurse
2.4
10.1
107
558
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
10.0
90
430
L04AX01
ATC
azathioprine; systemic
5.9
9.9
27
49
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
20.8
9.9
14
7
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.8
9.7
27
50
WF002
NOMESCO Finland
Radical radiotherapy
56.7
9.7
11
*
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
56.7
9.7
11
*
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
9.4
9
*
115
Kela drug reimbursment
Breast cancer
+∞
9.4
9
*
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
A11CC03
ATC
alfacalcidol; systemic
7.1
9.3
22
33
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
9.2
87
426
XKD00
NOMESCO Finland
Uroflowmetry
2.5
9.0
77
357
D07AB08
ATC
desonide; topical
3.0
8.8
53
197
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.0
8.7
34
92
TQW40
NOMESCO Finland
Remowal of suture of skin
4.5
8.7
30
72
-54
ICPC
Repair/fix-suture/cast/prosth device
6.3
8.6
22
37
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
92.3
8.4
9
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
13.2
8.4
14
11
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
8.4
8
*
WZC30
NOMESCO Finland
Teaching
3.3
8.3
42
140
D06BX02
ATC
ingenol mebutate; topical
8.5
8.2
17
21
137
Kela drug reimbursment
Uraemia requiring dialysis
17.7
8.1
12
7
B01AB05
ATC
enoxaparin; parenteral
2.1
8.1
111
639
QAA99
NOMESCO Finland
Other local destruction of skin of head or neck
34.2
8.1
10
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
7.9
44
155
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
13.5
7.9
13
10
ZXE00
NOMESCO Finland
One hour or less
2.0
7.9
136
856
A04AA01
ATC
ondansetron; systemic, rectal
7.0
7.7
18
27
A46
ICD-10 Finland
Erysipelas
2.4
7.6
71
340
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
10.4
7.6
14
14
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.4
7.6
71
341
JN4AD
NOMESCO Finland
Body CT examination
5.3
7.6
22
44
S21
ICPC
Skin texture symptom/complaint
2.6
7.5
57
247
L03AA02
ATC
filgrastim; parenteral
81.8
7.4
8
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
81.8
7.4
8
*
QXA05
NOMESCO Finland
Skin division, unspecified location
81.8
7.4
8
*
H02AB02
ATC
dexamethasone; systemic
13.8
7.4
12
9
Z49.1
ICD-10 Finland
Extracorporeal dialysis
13.8
7.4
12
9
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
11.2
7.4
13
12
TK800
NOMESCO Finland
Hemodialysis
9.7
7.4
14
15
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
6.0
7.3
19
33
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
7.3
7
*
205
Kela drug reimbursment
Chronic hypertension
1.9
7.3
141
921
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.3
7.2
36
119
DHB00
NOMESCO Finland
Excision of lesion of external nose
30.7
7.2
9
*
B01AB10
ATC
tinzaparin; parenteral
4.4
7.2
25
61
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.9
7.1
152
1028
C02CA01
ATC
prazosin; oral
5.4
7.1
20
39
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.5
6.9
14
17
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
11.3
6.8
12
11
UJF32
NOMESCO Finland
Coloscopy
2.0
6.8
96
554
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
40.9
6.8
8
*
UKC02
NOMESCO Finland
Cystoscopy
2.2
6.6
69
348
ZXC10
NOMESCO Finland
Use of laser
7.1
6.6
15
22
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
5.5
6.6
18
34
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.5
6.6
29
88
SPAT1325
SPAT
Vaccination
1.8
6.5
144
979
H02AB04
ATC
methylprednisolone; systemic
2.3
6.4
60
288
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
71.1
6.4
7
*
L02BB03
ATC
bicalutamide; oral
71.1
6.4
7
*
WXQ99
NOMESCO Finland
Other light therapy
71.1
6.4
7
*
S82
ICPC
Naevus/mole
2.7
6.4
42
167
HA1AA
NOMESCO Finland
X-ray mammography
6.8
6.4
15
23
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.8
6.4
15
23
J05AB01
ATC
aciclovir; systemic
2.2
6.4
68
348
SPAT1312
SPAT
General health counselling
1.9
6.4
111
692
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
11.3
6.3
11
10
L57.9
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation, unspecified
18.4
6.3
9
5
XJH00
NOMESCO Finland
Transanal ultrasonography
3.0
6.3
35
124
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
6.3
6
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
6.3
6
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
6.3
6
*
7151
FHL
Kidney transplantation
+∞
6.3
6
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
6.3
6
*
H26.3
ICD-10 Finland
Drug-induced cataract
27.2
6.3
8
*
L85.80
ICD-10 Finland
Hudhorn
27.2
6.3
8
*
ZY010
NOMESCO Finland
Hospital outpatient
5.5
6.2
17
32
CBB30
NOMESCO Finland
Excision of lesion of eyelid
5.5
6.2
17
32
B03XA02
ATC
darbepoetin alfa; parenteral
7.9
6.2
13
17
B02.9
ICD-10 Finland
Zoster without complication
3.4
6.2
28
87
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.1
6.1
18
37
S15
ICPC
Foreign body in skin
3.6
6.1
26
77
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
6.2
6.1
15
25
A03FA01
ATC
metoclopramide; systemic, rectal
2.6
6.0
45
192
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
162
193
13.58
136.15
2.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
296
835
11.31
118.27
5.4
1.6
—
—
—
0
0
(4035726)
76
63
14.72
78.56
1.4
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
52
111
5.25
23.65
1.4
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
290
1860
3.13
22.60
5.7
4.2
mmol/l
6.8
6.9
0.72
279
1728
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
97
345
3.41
22.10
5.3
3.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
33
48
7.41
21.98
4.2
2.5
%
60.1
61.0
0.10
33
48
(3030905) Polymorphonuclear cells [#/volume] in Blood
32
46
7.48
21.53
3.2
2.1
e9/l
5.2
4.9
0.18
32
46
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
258
1619
2.73
19.74
10.0
5.2
mmol/l
1.2
1.2
0.40
193
1373
(3002179) Metamyelocytes/100 leukocytes in Blood
64
186
3.92
19.61
4.6
3.8
%
0.3
0.3
0.02
23
35
(40760892) CBC W Ordered Manual Differential panel - Blood
122
530
2.89
19.44
6.3
4.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
66
202
3.72
18.75
4.7
3.7
%
0.0
0.1
0.24
25
42
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
202
1155
2.54
18.28
5.4
3.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
211
1234
2.53
18.16
17.9
8.4
e9/l
0.0
0.0
0.23
183
1000
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
75
256
3.38
18.00
8.5
2.9
mmol/l
1.2
1.2
0.19
63
212
(3025159) Blasts/100 leukocytes in Blood
62
188
3.73
17.82
4.8
3.8
%
0.1
0.0
0.28
23
36
(3017181) Myelocytes/100 leukocytes in Blood
66
209
3.59
17.78
4.9
3.6
%
0.6
0.8
0.41
25
46
(3013115) Eosinophils [#/volume] in Blood
232
1429
2.52
17.69
8.5
4.9
e9/l
0.2
0.2
1.52
202
1220
(3024561) Albumin [Mass/volume] in Serum or Plasma
225
1375
2.49
17.33
6.5
3.5
g/l
34.1
34.8
1.07
212
1251
(3006315) Basophils [#/volume] in Blood
225
1376
2.49
17.29
8.3
4.7
e9/l
0.0
0.0
1.50
199
1166
(3001604) Monocytes [#/volume] in Blood
224
1370
2.48
17.17
8.3
4.7
e9/l
0.6
0.6
0.27
199
1152
(3007853) Bacteria identified in Skin by Aerobe culture
88
343
3.02
16.84
2.5
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
225
1393
2.44
16.58
8.4
4.8
e9/l
2.9
1.8
1.06
202
1198
(3002582) Erythrocytes [#/volume] in Urine
175
970
2.45
16.51
5.0
3.1
e6/l
67.5
135.9
0.42
150
749
(3013650) Neutrophils [#/volume] in Blood by Automated count
240
1532
2.46
16.48
12.1
5.5
e9/l
4.2
4.5
1.14
220
1307
(3023368) Bacteria identified in Blood by Culture
168
920
2.44
16.21
6.5
3.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
232
1477
2.39
15.76
7.1
3.5
umol/l
12.3
12.2
0.11
219
1365
(3018095) Leukocytes [#/volume] in Urine
190
1116
2.36
15.45
5.5
3.6
e6/l
298.1
120.9
0.84
159
802
(42870588) Differential panel, method unspecified - Blood
165
917
2.38
15.18
9.5
4.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
309
2264
2.71
15.04
10.8
5.0
u/l
81.3
78.2
0.29
298
2054
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
26
44
6.26
14.98
2.2
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
161
900
2.34
14.46
5.0
3.0
e6/l
0.4
0.5
0.40
135
678
(3000850) Epithelial cells [#/volume] in Urine
135
699
2.42
14.44
4.5
2.4
e6/l
3.9
5.2
0.87
125
597
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
344
2690
3.24
14.30
26.9
14.2
ml/min/173m2
63.9
69.8
5.54
308
2167
(1616796) Gas panel - Central venous blood
32
69
4.96
14.27
5.3
3.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
67
245
3.09
14.20
8.4
3.7
—
—
—
0
0
(3026782) Osmolality of Urine
128
652
2.43
14.16
4.6
2.6
mosm/kgh2o
502.6
547.1
2.15
115
530
(3006504) Eosinophils/100 leukocytes in Blood
204
1274
2.25
13.90
9.5
4.9
%
2.6
2.9
1.71
193
1150
(3044640) Blood type and Crossmatch panel - Blood
153
853
2.30
13.67
2.9
2.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
199
1237
2.23
13.64
9.6
4.9
%
0.6
0.6
0.67
188
1122
(3019069) Monocytes/100 leukocytes in Blood
204
1282
2.23
13.60
9.8
5.1
%
9.0
8.9
0.30
194
1163
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
30
64
4.99
13.53
1.8
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
299
2211
2.47
13.32
5.7
4.2
mm/h
17.6
14.1
2.13
272
1975
(3032080) INR in Blood by Coagulation assay
217
1406
2.21
13.31
16.5
11.7
inr
1.3
1.4
0.72
86
391
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
30
65
4.91
13.29
2.2
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
205
1300
2.21
13.25
9.6
5.1
%
25.9
25.7
0.08
194
1170
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
223
1463
2.21
13.22
9.8
4.8
mmol/l
1.2
1.2
0.07
194
1283
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
358
2904
3.61
13.17
28.7
15.0
mg/l
24.3
26.5
0.62
321
2308
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
37
6.24
12.73
2.5
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
176
1065
2.18
12.64
4.2
2.1
mmol/l
2.3
2.4
0.75
157
859
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
28
61
4.87
12.32
2.2
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
197
1257
2.14
12.23
5.0
3.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
366
3048
3.92
12.09
15.4
9.3
u/l
22.0
23.3
1.13
355
2879
(36304419) Bacteria [Presence] in Urine
148
854
2.18
11.82
5.1
2.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
199
1287
2.11
11.79
8.9
4.9
%
58.6
59.0
0.15
188
1174
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
30
6.60
11.65
2.6
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
50
173
3.17
11.56
2.5
1.3
ug/l
3.1
4.6
0.42
42
136
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
336
2692
2.71
11.46
5.1
4.6
mu/l
2.0
2.0
0.27
296
2368
(3007461) Platelets [#/volume] in Blood
372
3154
4.36
11.44
39.8
22.1
e9/l
228.8
238.1
1.82
366
3047
(3026361) Erythrocytes [#/volume] in Blood
372
3155
4.35
11.42
39.8
22.1
e12/l
4.2
4.4
7.91
363
3033
(3010813) Leukocytes [#/volume] in Blood
372
3156
4.34
11.39
39.9
22.1
e9/l
7.7
6.9
1.34
364
3033
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
197
1283
2.07
11.31
3.5
3.2
ng/l
2500.7
1941.6
0.79
180
1109
(3026250) Tacrolimus [Mass/volume] in Blood
15
6
25.89
11.22
29.7
34.8
ug/l
5.9
6.8
—
10
6
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
289
2178
2.24
11.18
4.1
3.6
pmol/l
15.2
15.1
0.05
258
1907
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
23
46
5.25
11.13
7.6
3.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
358
2978
3.27
11.09
27.1
14.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
280
2094
2.17
10.89
6.5
4.9
e6/l
237.4
3663.0
—
10
38
(3013512) EKG study
167
1036
2.06
10.82
4.8
4.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
92
456
2.33
10.47
4.2
2.4
%
22.9
21.9
0.28
78
383
(3035350) Ketones [Presence] in Urine by Test strip
216
1485
2.01
10.36
6.1
4.1
estimate
0.0
0.0
0.00
71
252
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
25
58
4.54
10.20
2.1
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
155
953
2.03
10.14
9.3
3.1
ph
7.4
7.4
0.18
49
152
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
339
2778
2.60
10.11
8.1
6.8
mmol/mol
41.5
41.3
0.14
303
2506
(3021601) Nitrite [Presence] in Urine by Test strip
215
1490
1.98
9.93
7.7
5.4
estimate
0.0
0.0
0.00
68
241
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
211
1453
1.98
9.92
5.4
4.2
ng/l
48.4
66.7
0.38
183
1135
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
22
7.05
9.80
2.3
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
186
1231
1.97
9.78
3.8
2.8
ug/l
154.2
135.3
0.69
168
1099
(3037467) Urinalysis macro (dipstick) panel - Urine
280
2136
2.08
9.75
7.0
4.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
217
1515
1.97
9.74
6.1
4.1
estimate
0.0
0.0
0.00
67
245
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
11
10.26
9.58
3.5
5.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
89
451
2.26
9.54
4.4
2.2
mmol/l
0.8
0.8
1.02
82
412
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
110
607
2.13
9.54
2.4
1.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
94
489
2.21
9.45
4.2
2.3
g/l
2.2
2.2
0.47
82
444
(3004809) Band form neutrophils/100 leukocytes in Blood
17
30
5.88
9.35
4.6
3.0
%
1.2
0.5
0.85
12
22
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
150
934
1.98
9.30
2.5
2.3
mg/l
3.5
3.1
1.01
130
775
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
34
5.50
9.24
1.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
86
436
2.24
9.19
2.2
1.8
—
—
—
0
0
(3012501) Base excess in Blood by calculation
28
77
3.84
9.17
7.0
3.5
mmol/l
3.1
2.7
0.44
22
46
(3041096) Erythrocytes [Presence] in Urine by Automated
128
761
2.01
9.00
6.8
3.7
—
—
—
0
0
(3015736) pH of Urine
177
1180
1.91
8.86
5.2
3.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
100
550
2.10
8.65
4.2
2.3
umol/l
12.4
12.4
0.01
86
492
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
191
2.72
8.61
2.1
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
345
2913
2.51
8.53
6.1
5.5
mmol/l
2.4
2.5
2.41
307
2591
(3044889) 12 lead EKG panel
276
2155
1.94
8.21
5.7
4.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
171
1149
1.86
8.18
6.8
4.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
180
1231
1.85
8.13
2.8
2.2
nmol/l
84.2
78.9
1.74
156
1046
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
11
9.30
8.12
2.5
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
11
9.30
8.12
2.5
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
336
2822
2.31
8.11
5.7
4.8
mmol/l
4.3
4.4
0.87
300
2505
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
14
8.05
8.02
2.4
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
24
66
3.81
7.86
2.7
2.1
%
14.4
15.5
0.63
14
34
(3017143) Hepatitis C virus Ab [Presence] in Serum
44
178
2.66
7.64
2.4
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
331
2783
2.20
7.64
5.5
4.8
mmol/l
1.5
1.4
1.29
292
2453
(3026493) Urate [Moles/volume] in Serum or Plasma
128
802
1.88
7.50
4.7
2.6
umol/l
4202.4
10573.4
0.79
108
666
(3029937) Albumin [Presence] in Urine by Test strip
132
837
1.87
7.44
7.0
4.3
estimate
0.0
0.0
0.00
67
237
(3028026) IgM [Mass/volume] in Serum or Plasma
36
133
2.88
7.41
2.4
1.4
g/l
1.5
1.1
0.42
30
121
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
110
658
1.93
7.40
3.0
2.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
143
932
1.84
7.37
3.1
2.1
u/l
52.9
57.8
1.24
125
849
(1761868) Lipid panel - Serum or Plasma
124
773
1.88
7.36
4.8
3.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
19
6.48
7.28
1.2
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
321
2690
2.06
7.13
5.2
4.3
mmol/l
1.2
1.2
0.81
281
2334
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
116
2.91
6.82
3.2
2.5
u/ml
0.4
0.4
0.11
20
67
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
48
221
2.33
6.35
2.2
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
62
319
2.12
6.27
1.7
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
77
431
1.98
6.20
2.1
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
180
1303
1.70
6.20
2.4
2.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
40
4.13
5.95
2.6
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
50
242
2.22
5.88
2.6
2.5
ml/min/173m2
46.2
56.2
1.38
33
108
(3042631) Mycobacterium sp identified in Specimen
15
36
4.29
5.87
3.8
3.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
49
236
2.23
5.83
2.2
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
50
3.72
5.83
2.6
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
34
139
2.58
5.79
1.9
1.6
ug/l
0.8
2.4
0.89
29
115
(3022145) Colonoscopy Study observation
53
265
2.16
5.76
1.3
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
98
613
1.80
5.56
1.9
1.7
mg/l
1.5
1.3
0.29
79
477
(3017354) Segmented neutrophils/100 leukocytes in Blood
11
21
5.36
5.55
3.6
2.5
%
76.8
52.6
—
6
14
(3021901) Oxygen saturation in Capillary blood
20
62
3.35
5.52
2.5
2.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
113
2.69
5.43
3.2
3.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
74
429
1.89
5.34
2.1
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
8
11.48
5.31
1.6
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
156
1122
1.65
5.29
4.4
3.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
78
463
1.85
5.22
2.4
2.2
%
1.5
1.7
1.61
69
404
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
152
1091
1.64
5.17
2.9
2.1
u/l
189.9
236.1
0.47
143
1011
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
331
2900
1.90
5.12
6.3
5.1
mmol/l
6.1
6.2
0.32
291
2549
(3020682) Albumin/Creatinine [Ratio] in Urine
157
1140
1.63
5.08
5.6
3.9
mg/mmol
11.9
7.7
0.48
99
725
(3025941) Bacteria identified in Stool by Culture
33
143
2.43
5.00
1.5
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
41
3.76
4.97
2.1
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
119
809
1.68
4.96
3.6
2.4
u/l
32.2
34.5
0.40
110
775
(3009542) Hematocrit [Volume Fraction] of Blood
289
2446
1.69
4.92
24.9
16.9
%
36.7
38.6
1.69
149
1439
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
37
3.89
4.85
2.1
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
120
826
1.65
4.74
1.9
1.8
pmol/l
442.3
17781588.8
0.80
92
658
(3027456) Digoxin [Moles/volume] in Serum or Plasma
26
103
2.63
4.73
3.2
3.6
nmol/l
0.7
0.9
1.56
20
82
(40758558) Short blood count panel - Blood
99
654
1.69
4.56
8.9
4.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
166
1250
1.57
4.47
5.9
4.2
ug/l
6.5
2.3
0.58
140
1100
(3012516) Albumin [Mass/volume] in Urine
146
1069
1.58
4.43
3.9
3.1
mg/l
189.2
215.3
0.06
96
672
(3002032) Base excess in Venous blood by calculation
60
345
1.87
4.42
5.0
3.1
mmol/l
2.0
2.2
0.25
54
277
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
37
180
2.17
4.32
3.2
2.3
%
1.1
1.1
0.32
37
180
(3022806) Fractional oxyhemoglobin in Capillary blood
14
41
3.50
4.22
2.1
1.5
%
86.4
90.0
0.70
14
41
(3037756) Immunofixation for Serum or Plasma
17
57
3.07
4.17
1.8
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
41
211
2.05
4.15
1.5
1.6
—
—
—
0
0
(3020891) Body temperature
32
151
2.22
4.03
4.9
3.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
45
244
1.95
3.95
3.1
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
99
677
1.62
3.93
3.1
2.3
mmol/l
2.5
2.5
1.20
92
570
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
201
1615
1.50
3.83
3.3
2.8
u/l
61.6
49.1
0.91
187
1437
(3009508) Creatinine [Moles/volume] in Urine
144
1080
1.53
3.81
3.9
3.0
mmol/l
6.2
7.1
2.70
113
890
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
66
2.81
3.81
1.3
1.2
ug/g
329.3
316.5
—
9
36
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
84
557
1.65
3.76
3.8
2.6
e6/l
1.2
1.4
0.15
54
320
(40768806) Pleura Pathology biopsy report
11
30
3.74
3.66
1.7
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
127
934
1.53
3.66
1.7
1.6
nmol/l
23.2
20.0
1.04
108
785
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
23
98
2.43
3.65
2.9
1.3
—
1.4
—
0
11
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
190
1525
1.48
3.55
2.2
2.2
pmol/l
96.5
92.7
0.49
100
796
(3023520) Reticulocytes [#/volume] in Blood
58
353
1.75
3.55
4.0
2.5
e9/l
56.7
67.0
1.99
43
285
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
93
2.45
3.55
4.9
2.3
ug/min
67.1
52.7
0.14
15
57
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
26
3.92
3.54
1.5
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
33
167
2.07
3.51
1.8
1.8
g/l
1.4
1.6
0.56
27
144
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
6
10.13
3.51
1.5
1.0
u/ml
13.3
15.7
—
6
6
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
77
510
1.63
3.45
3.8
2.8
e6/l
3.0
2.9
0.03
47
275
(3034860) Kappa light chains.free [Mass/volume] in Serum
23
102
2.33
3.36
2.9
1.3
mg/l
62.0
46.2
0.56
15
83
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
23
102
2.33
3.36
2.9
1.3
mg/l
28.8
31.6
0.15
15
83
(40760888) Immunoglobulin light chains.free panel - Serum
18
71
2.61
3.34
3.1
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
137
2.12
3.25
2.2
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
68
443
1.65
3.25
1.7
1.2
g/l
3.0
2.7
0.38
47
232
(3000991) Gas panel - Venous blood
46
269
1.80
3.22
7.5
5.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
28
3.64
3.21
1.5
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
8
15
5.42
3.20
1.4
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
11
6.46
3.20
1.6
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
11
6.46
3.20
1.6
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
11
6.46
3.20
1.6
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
11
6.46
3.20
1.6
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
39
217
1.89
3.19
4.1
3.9
ph
7.4
7.4
1.51
11
26
(3035880) pH of Pleural fluid
9
20
4.58
3.13
1.4
1.4
—
—
—
0
0
(4010399)
40
226
1.86
3.13
1.7
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
147
2.05
3.09
2.5
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
34
3.30
3.08
2.3
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
43
250
1.81
3.08
1.8
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
207
1.87
2.99
4.0
3.9
mmol/l
2.0
2.1
0.09
29
157
(40757373) Influenza virus identified in Isolate
5
5
10.10
2.98
2.8
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
15
58
2.65
2.91
1.2
1.4
mmol/l
52.9
61.3
—
9
45
(3030981) Hyaline casts [#/volume] in Urine by Automated count
32
173
1.93
2.87
4.3
2.6
e6/l
0.4
0.2
0.37
32
165
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
23
3.98
2.79
1.4
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
23
3.98
2.79
1.4
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
23
3.98
2.79
1.4
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
6
8.42
2.75
1.4
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
6
8.42
2.75
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
112
2.12
2.73
1.3
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
6
10
6.07
2.70
1.5
1.7
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
12
43
2.85
2.67
1.6
1.4
g/l
30.5
25.0
0.96
12
37
(3019230) Fractional oxyhemoglobin in Venous blood
14
56
2.56
2.56
3.5
1.8
%
64.1
64.2
0.01
14
56
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
91
668
1.47
2.55
3.6
2.8
ug/l
0.7
0.8
0.89
64
484
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
7
7.22
2.55
1.8
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
7
7.22
2.55
1.8
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
7
7.22
2.55
1.8
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
11
5.52
2.55
1.5
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
33
3.08
2.54
1.9
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
26
3.52
2.49
5.3
2.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
26
3.52
2.49
3.0
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
19
90
2.17
2.43
4.3
3.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
12
5.06
2.41
3.0
1.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
21
105
2.06
2.35
2.4
1.2
g/l
1.0
0.3
0.84
15
88
(3021879) Hepatitis B virus core Ab [Presence] in Serum
21
106
2.04
2.30
1.6
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
23
3.53
2.28
1.6
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
86
2.15
2.26
1.4
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
18
3.94
2.26
1.3
1.2
—
—
—
0
0
(4062490)
7
19
3.73
2.16
1.1
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
14
4.33
2.16
1.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
15
4.04
2.04
2.0
2.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
15
4.04
2.04
1.8
1.3
u/l
198.5
205.1
—
6
15
(3023419) Bacteria identified in Sputum by Culture
12
50
2.44
2.04
2.3
3.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
210
1.68
2.02
1.5
1.3
—
—
—
0
0
(44790047)
9
32
2.85
2.01
2.4
1.4
—
—
—
0
0
(44790049)
9
32
2.85
2.01
2.4
1.4
—
—
—
0
0
(44790048)
9
32
2.85
2.01
2.4
1.4
—
—
—
0
0
(44806118)
9
32
2.85
2.01
2.4
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
11
4.59
1.94
3.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
11
4.59
1.94
2.6
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
11
4.59
1.94
2.6
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
39
2.60
1.93
4.2
3.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
94
732
1.37
1.88
1.7
1.6
mmol/l
1.2
1.2
0.22
70
593
(3019225) pH of Specimen
49
338
1.51
1.87
6.3
3.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
68
502
1.43
1.85
1.2
1.2
u/ml
0.8
1.6
0.94
18
128
(3019309) Folate [Moles/volume] in Red Blood Cells
106
845
1.35
1.82
2.2
1.8
nmol/l
1373.1
1153.6
1.28
81
631
(3019060) Gas panel - Arterial blood
38
249
1.58
1.81
3.1
3.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
74
2.07
1.77
3.4
2.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
16
81
2.02
1.77
1.1
1.2
—
0.2
—
0
9
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
54
385
1.47
1.76
2.2
2.6
ug/l
6.0
6.1
0.02
44
333
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
42
284
1.54
1.76
7.5
3.5
ng/l
160.7
87.5
1.01
35
240
(21494890) Protein electrophoresis panel - 24 hour Urine
8
30
2.70
1.73
1.9
1.1
—
—
—
0
0
(4281824)
5
13
3.88
1.72
1.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
121
993
1.32
1.70
5.3
4.1
%
22.6
25.2
1.29
74
530
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
24
142
1.74
1.69
2.4
1.9
ug/l
289.8
374.0
0.31
24
130
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
31
2.61
1.66
1.5
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
31
2.61
1.66
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
19
3.19
1.66
1.2
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
25
2.83
1.65
1.4
1.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
35
234
1.54
1.56
2.5
1.9
ug/g
118.5
171.3
0.72
27
176
(3000093) Morphology [Interpretation] in Blood Narrative
8
33
2.45
1.54
1.0
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
15
3.36
1.53
1.2
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
51
2.19
1.52
2.2
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
21
2.88
1.51
1.7
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
21
2.88
1.51
1.7
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
54
400
1.41
1.46
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
28
2.53
1.46
5.0
2.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
16
3.15
1.44
1.0
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
29
2.44
1.40
2.9
1.7
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
17
2.96
1.36
1.0
1.8
u/field
5.6
3.7
—
5
11
(3003327) Ova and parasites identified in Stool by Light microscopy
11
54
2.07
1.34
1.9
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
45
329
1.42
1.32
1.3
1.3
titre
535.4
497.7
0.06
13
79
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
43
2.12
1.31
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.31
2.8
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
90
735
1.29
1.29
4.7
4.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
18
2.80
1.29
2.2
1.3
ug/l
15.3
16.8
—
5
18
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
37
262
1.46
1.28
2.2
2.0
u/l
24.7
29.7
1.18
29
209
(3003396) Base excess in Arterial blood by calculation
53
401
1.37
1.28
4.9
5.2
mmol/l
1.7
1.6
0.13
39
308
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
139
1.62
1.26
3.5
1.2
g/l
4.2
3.8
0.30
16
90
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
139
1.62
1.26
3.5
1.2
g/l
7.7
7.6
0.06
17
94
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
139
1.62
1.26
3.5
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
196
1.52
1.26
2.2
2.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
2.8
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
19
2.65
1.22
1.2
1.9
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
19
2.65
1.22
1.2
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
18
109
1.68
1.21
3.2
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
43
321
1.38
1.14
5.1
3.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
40
2.02
1.12
1.3
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
71
573
1.29
1.12
44.4
30.4
inr
1.3
1.4
—
10
71
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
32
2.21
1.08
1.9
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
34
2.08
1.03
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
61
1.83
0.99
1.1
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
23
157
1.49
0.98
5.1
4.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
251
1.39
0.98
1.6
1.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
11
62
1.80
0.95
3.1
2.1
mg/l
13.5
12.2
0.23
11
56
(3000330) Specific gravity of Urine by Test strip
29
210
1.41
0.93
5.9
3.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
27
193
1.43
0.93
4.8
2.7
mmol/l
26.1
25.4
0.70
27
188
(3047181) Lactate [Moles/volume] in Blood
5
104
0.47
0.90
2.6
4.9
mmol/l
1.6
1.2
—
5
94
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
30
2.02
0.87
1.3
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
75
630
1.24
0.87
1.5
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
96
1.58
0.85
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
48
1.68
0.79
1.3
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
19
132
1.46
0.77
2.3
2.5
pmol/l
4.4
4.2
0.46
14
117
(3000012) Reticulocyte production index
5
25
2.01
0.73
1.4
1.9
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
26
1.93
0.71
1.2
1.4
—
—
—
0
0
(4024509)
5
27
1.86
0.68
2.4
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
119
1.45
0.68
7.2
4.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
86
1.53
0.67
1.7
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
23
172
1.36
0.65
1.3
1.7
%
1.8
1.7
0.09
18
144
(3021387) Prolactin [Units/volume] in Serum or Plasma
5
29
1.73
0.64
2.8
1.9
mu/l
513.2
324.3
—
5
29
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
30
1.68
0.61
2.0
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
53
1.52
0.58
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
53
1.52
0.58
2.3
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
124
1.39
0.56
1.5
2.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
40
1.51
0.52
1.2
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
64
1.42
0.52
2.6
2.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
9
65
1.39
0.51
2.6
2.4
mmol/l
104.6
105.4
—
9
65
(3041354) Potassium [Moles/volume] in Venous blood
9
65
1.39
0.51
2.6
2.4
mmol/l
4.2
4.1
—
9
65
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
53
458
1.18
0.49
11.4
8.5
—
—
—
0
0
(4034850)
17
128
1.34
0.48
12.8
13.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
51
442
1.18
0.46
1.2
1.3
iu/ml
19.3
39.8
2.44
18
142
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
49
1.44
0.46
2.0
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
77
1.44
0.46
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
77
1.44
0.46
1.6
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
12
86
1.41
0.45
2.5
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
32
1.57
0.42
1.4
1.1
pmol/l
334.6
306.7
—
5
24
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
8
57
1.41
0.42
1.1
1.1
u/l
32.0
18.6
—
8
50
(1002224) Polysomnography panel
10
70
1.44
0.42
1.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.1
—
38.4
—
0
8
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
4.1
—
31.0
—
0
10
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
35
1.43
0.39
1.6
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
4.4
—
0
5
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
36
1.39
0.38
1.4
1.2
nmol/l
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
36
1.39
0.38
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
98
1.34
0.38
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
98
1.34
0.38
1.4
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
158
0.75
0.38
8.6
7.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
71
1.27
0.36
1.4
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
76
0.65
0.36
1.6
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
43
1.40
0.35
3.7
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
100
1.31
0.34
1.4
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
88
0.68
0.33
1.8
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
54
1.30
0.30
1.9
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
77
711
1.10
0.30
6.1
4.6
kg/l
1.0
1.0
—
10
108
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
107
0.74
0.29
3.0
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
14
173
0.80
0.29
1.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
74
1.22
0.25
1.3
1.3
—
—
—
0
0
(3000492) Spirometry study
23
199
1.17
0.24
2.3
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
13
106
1.23
0.23
4.6
1.9
g/l
0.3
0.3
—
5
26
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
40
1.25
0.22
1.4
1.2
nmol/l
0.7
0.5
—
5
35
(3001019) Free T4 and TSH panel - Serum or Plasma
5
42
1.19
0.21
3.0
1.5
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
11
0.00
0.21
0.0
1.9
—
1.2
—
0
11
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
10
0.00
0.21
0.0
1.1
—
3.7
—
0
5
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.2
—
42.7
—
0
10
(44813793)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.3
—
1.0
—
0
7
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
164
1.17
0.20
1.2
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.0
—
149.4
—
0
14
(40762814) Titanium [Mass/volume] in Blood
0
14
0.00
0.20
0.0
2.1
—
2.8
—
0
5
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
14
0.00
0.20
0.0
1.1
—
217.3
—
0
8
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
77
726
1.08
0.20
4.5
4.1
ng/l
200.4
252.5
0.21
71
629
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
51
1.18
0.19
1.5
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
30
270
1.12
0.19
1.2
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
58
1.21
0.18
1.3
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
58
1.21
0.18
1.7
1.2
mmol/l
4.2
4.1
—
7
53
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
119
1.18
0.18
1.4
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
17
149
1.15
0.16
3.2
3.7
%
0.7
0.9
2.11
17
144
(3014051) Protein [Presence] in Urine by Test strip
10
83
1.21
0.15
1.4
2.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
17
151
1.13
0.13
3.2
3.6
%
1.2
1.6
1.86
17
146
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
45
428
1.06
0.10
4.9
5.1
%
39.5
33.4
2.25
32
266
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
87
1.15
0.09
2.8
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
22
236
0.93
0.08
3.1
3.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
64
1.10
0.08
1.9
1.3
e6/l
43.3
369.1
—
7
56
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
7
64
1.10
0.08
1.6
1.2
e6/l
2.4
2.9
—
7
54
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
66
1.06
0.08
1.6
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
84
0.83
0.07
1.1
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
85
1.06
0.07
1.1
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
43
415
1.04
0.05
1.1
1.3
u/ml
4.1
12.3
1.19
13
133
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
17
178
0.95
0.02
2.9
2.4
—
15.3
—
0
5
(3017732) Neutrophils [#/volume] in Blood
18
188
0.96
0.02
3.7
2.9
e9/l
2.9
4.0
—
10
125
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
15
154
0.97
0.00
1.9
1.3
—
51.4
—
0
10
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
57
0.88
0.00
1.0
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
71
0.99
0.00
2.1
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.2
—
86.0
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.2
—
88.0
—
0
5
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
4.5
—
120.5
—
0
8
(3034426) Prothrombin time (PT)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(4094501)
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
88.8
—
0
6
(3009871) Measles virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.1
—
72.3
—
0
8
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
7.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
5.0
—
150.8
—
0
6
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
17.1
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_NOS_EXALLC – Carcinoma in situ of skin, other sites/unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).